Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Smith

Showing results (461-470 of 473) with videos related to

Pageof 48
Sort By:
Diseases of Aquatic Organisms|December 12, 2024
Epidemiological cut-off values for Vibrio parahaemolyticus calculated from minimal inhibitory concentration data generated at 35 and 28°CPeter Smith, Andrew Joseph, Craig Baker-Austin, et al.
JAMA|February 23, 2019
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical TrialDavid M Fleischer, Matthew Greenhawt, Gordon Sussman, et al.
Cancer Research|January 24, 2012
ARN-509: a novel antiandrogen for prostate cancer treatmentNicola J Clegg, John Wongvipat, James D Joseph, et al.
Journal of Medicinal Chemistry|October 2, 2014
Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistance mutations that spares the wild type form of the receptorM Raymond V Finlay, Mark Anderton, Susan Ashton, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2020
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year resultsDavid M Fleischer, Wayne G Shreffler, Dianne E Campbell, et al.
Nature Biotechnology|April 9, 2020
Efficient production of male Wolbachia-infected Aedes aegypti mosquitoes enables large-scale suppression of wild populationsJacob E Crawford, David W Clarke, Victor Criswell, et al.
Nature Biotechnology|July 26, 2020
Author Correction: Efficient production of male Wolbachia-infected Aedes aegypti mosquitoes enables large-scale suppression of wild populationsJacob E Crawford, David W Clarke, Victor Criswell, et al.
The New England Journal of Medicine|April 1, 2014
Darapladib for preventing ischemic events in stable coronary heart disease, Harvey D White, Claes Held, et al.
Influenza and Other Respiratory Viruses|February 24, 2023
Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019-2020Thomas Williams, Sandra Jackson, Ian Barr, et al.
Allergy|October 30, 2024
EAACI guidelines on the management of IgE-mediated food allergyAlexandra F Santos, Carmen Riggioni, Ioana Agache, et al.
Pageof 48

Showing results (461-470 of 473) with videos related to

Sort By:
Pageof 48
Diseases of Aquatic Organisms|December 12, 2024
Epidemiological cut-off values for Vibrio parahaemolyticus calculated from minimal inhibitory concentration data generated at 35 and 28°CPeter Smith, Andrew Joseph, Craig Baker-Austin, et al.
JAMA|February 23, 2019
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical TrialDavid M Fleischer, Matthew Greenhawt, Gordon Sussman, et al.
Cancer Research|January 24, 2012
ARN-509: a novel antiandrogen for prostate cancer treatmentNicola J Clegg, John Wongvipat, James D Joseph, et al.
Journal of Medicinal Chemistry|October 2, 2014
Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistance mutations that spares the wild type form of the receptorM Raymond V Finlay, Mark Anderton, Susan Ashton, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2020
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year resultsDavid M Fleischer, Wayne G Shreffler, Dianne E Campbell, et al.
Nature Biotechnology|April 9, 2020
Efficient production of male Wolbachia-infected Aedes aegypti mosquitoes enables large-scale suppression of wild populationsJacob E Crawford, David W Clarke, Victor Criswell, et al.
Nature Biotechnology|July 26, 2020
Author Correction: Efficient production of male Wolbachia-infected Aedes aegypti mosquitoes enables large-scale suppression of wild populationsJacob E Crawford, David W Clarke, Victor Criswell, et al.
The New England Journal of Medicine|April 1, 2014
Darapladib for preventing ischemic events in stable coronary heart disease, Harvey D White, Claes Held, et al.
Influenza and Other Respiratory Viruses|February 24, 2023
Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019-2020Thomas Williams, Sandra Jackson, Ian Barr, et al.
Allergy|October 30, 2024
EAACI guidelines on the management of IgE-mediated food allergyAlexandra F Santos, Carmen Riggioni, Ioana Agache, et al.
Pageof 48